Standout Papers

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small... 2007 2026 2013 2019 700
  1. Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial (2007)
    U. Gatzemeier, A Płużańska et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 90 standout
Sub-graph 1 of 18

Citing Papers

Neoadjuvant checkpoint blockade for cancer immunotherapy
2020 StandoutScience
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
2019 Standout
2 intermediate papers

Works of Jaromı́r Roubec being referenced

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
2007
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
Jaromı́r Roubec 1250 1249 62 568 19 1.6k
L. Fehrenbacher 1398 1337 49 347 32 1.7k
V. Alberola 993 1068 83 400 21 1.4k
J. A. Engelman 822 1002 50 505 24 1.2k
Xin Li 1121 1168 35 371 38 1.5k
Susan Coughlin 1481 1491 32 534 21 2.1k
C. Calandri 929 911 45 390 25 1.5k
Jacqui Rowbottom 1200 766 38 561 14 1.6k
Thomas Goddemeier 946 912 41 339 18 1.3k
Dana Ghiorghiu 794 911 41 487 35 1.3k
Vincent O’Neill 888 615 47 475 28 1.2k

All Works

Loading papers...

Rankless by CCL
2026